EDN1 and atherosclerosis: ET-1 is also involved in many pathophysiological processes, such as vascular oxidative stress, inflammation, reduced nitric oxide bioavailability, and impaired endothelium-dependent dilatation, and for this reason, it contributes to the development and progression of atherosclerosis [21,22].